Cigna Posts 4Q Revenue Rises on Growth of Evernorth Business

Dow Jones
Feb 05

By Kelly Cloonan

 

Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.

The healthcare company on Thursday posted a profit of $1.2 billion, or $4.64 a share, compared with $1.4 billion, or $5.13 a share, a year earlier.

Adjusted earnings per share were $8.08 a share, ahead of estimates of $7.88 a share according to analysts polled by FactSet.

Revenue rose 10% to $72.47 billion, topping analyst estimates of $70.31 billion.

The Bloomfield, Conn., company said growth was primarily driven by its Evernorth Health Services business, which includes pharmacy benefit services and specialty and care services. Adjusted revenue for Evernorth rose 17%.

The gain was partially offset by a 16% decline in adjusted revenue for Cigna's namesake segment. Cigna Healthcare provides medical plans and other benefits, and included Medicare and related businesses, until the company divested them last March.

For the full year, the company expects adjusted earnings per share of at least $30.25. Analysts forecast $30.30.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

February 05, 2026 06:00 ET (11:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10